Literature DB >> 19707037

Integrated profile to assess auditory nerve-auditory pathway integrity.

Wei-Jia Kong1, Hua-Mao Cheng, Yan-Jun Wang, Su-Lin Zhang, Wei Liu, Hui Ma, Ping Han, Xiang-Quan Kong.   

Abstract

PURPOSE: To evaluate the Integrated Cochlear Profile for Assessing Auditory Nerve-Auditory Pathway Integrity (ICP-API), as proposed by our group, in the selection of cochlear implant candidates. PROCEDURES: The API of the candidates for cochlear implantation were assessed with the ICP-API, which consists of 5 categories including: audiological testing; radiological imaging study; ear-canal electric response audiometry; response to environmental sounds; speech development level. The auditory rehabilitation effects of the cochlear implantation receivers were evaluated postoperatively.
RESULTS: Sixty-six of 68 candidates who met the criteria of the ICP-API received cochlear implantation with improved hearing and speech development postoperatively. The remaining 2 of the 68 candidates were diagnosed with bilateral auditory nerves aplasia, and therefore failed cochlear implants were avoided.
CONCLUSION: The ICP-API is valuable and feasible for the selection of cochlear implant candidates. The API should be considered as one of the most important criteria for cochlear implant candidate selection. 2009 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2009        PMID: 19707037     DOI: 10.1159/000229298

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  2 in total

Review 1.  Diagnostic yield of MRI for pediatric hearing loss: a systematic review.

Authors:  Bart Kachniarz; Jenny X Chen; Sapideh Gilani; Jennifer J Shin
Journal:  Otolaryngol Head Neck Surg       Date:  2014-11-11       Impact factor: 3.497

Review 2.  Diagnostic yield of computed tomography scan for pediatric hearing loss: a systematic review.

Authors:  Jenny X Chen; Bart Kachniarz; Jennifer J Shin
Journal:  Otolaryngol Head Neck Surg       Date:  2014-09-03       Impact factor: 3.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.